JP2016513523A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513523A5
JP2016513523A5 JP2015562517A JP2015562517A JP2016513523A5 JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5 JP 2015562517 A JP2015562517 A JP 2015562517A JP 2015562517 A JP2015562517 A JP 2015562517A JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5
Authority
JP
Japan
Prior art keywords
solution
item
bile
seq
target area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015562517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/059765 external-priority patent/WO2014141160A1/en
Publication of JP2016513523A publication Critical patent/JP2016513523A/ja
Publication of JP2016513523A5 publication Critical patent/JP2016513523A5/ja
Pending legal-status Critical Current

Links

JP2015562517A 2013-03-14 2014-03-13 胆汁漏の処置 Pending JP2016513523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784496P 2013-03-14 2013-03-14
US61/784,496 2013-03-14
PCT/IB2014/059765 WO2014141160A1 (en) 2013-03-14 2014-03-13 Treatment for bile leakage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018079164A Division JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Publications (2)

Publication Number Publication Date
JP2016513523A JP2016513523A (ja) 2016-05-16
JP2016513523A5 true JP2016513523A5 (https=) 2017-04-13

Family

ID=50397217

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562517A Pending JP2016513523A (ja) 2013-03-14 2014-03-13 胆汁漏の処置
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Country Status (5)

Country Link
US (1) US20160030628A1 (https=)
EP (1) EP2968654A1 (https=)
JP (2) JP2016513523A (https=)
HK (1) HK1220145A1 (https=)
WO (1) WO2014141160A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011118341A (ru) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
BR112016019510A2 (pt) 2014-03-10 2017-10-24 3 D Matrix Ltd esterilização e filtração de composições de peptídeos
RU2016139369A (ru) 2014-03-10 2018-04-10 3-Д Матрикс, Лтд. Композиции самоорганизующихся пептидов
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
BR112018068941A2 (pt) * 2016-03-18 2019-04-16 3-D Matrix, Ltd. prevenção de adesão de tecidos biológicos
EP3429646A1 (en) * 2016-03-18 2019-01-23 3-D Matrix, Ltd Pancreatic fistula occlusion
MX2018011201A (es) * 2016-03-18 2018-11-22 3 D Matrix Ltd Oclusion de fuga de liquido cefalorraquideo.
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5255274B2 (ja) * 2004-07-06 2013-08-07 スリーディー マトリックス, インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
DK1879606T3 (da) * 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase
RU2011118341A (ru) * 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
US8962784B2 (en) * 2008-12-19 2015-02-24 Ethicon, Inc. Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant

Similar Documents

Publication Publication Date Title
JP2016513523A5 (https=)
JP2016515113A5 (https=)
Tyler et al. Nanomedicine for treating spinal cord injury
ES2898655T3 (es) Métodos de reparación y regeneración de tejidos
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
JP2017513927A5 (https=)
Teng et al. An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes
JP2017519568A5 (https=)
JP2017513928A5 (https=)
WO2009055742A3 (en) Delivery of active agents
JP2018130552A (ja) 胆汁漏の処置
JP2016501066A5 (https=)
JP2017513927A (ja) 肺の漏出を治療するための自発組織化ペプチド
EP4309722A3 (en) Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
RU2016127558A (ru) Стероидное соединение для применения в лечении печеночной энцефалопатии
KR102200656B1 (ko) 마이크로스피어를 포함하는 개선된 창상 치료 조성물
JP2019508175A (ja) 膵液瘻の閉鎖
JP2016535044A (ja) 次亜塩素酸ナトリウムを含む抗炎症溶液
JP2019518569A5 (https=)
RU2018100879A (ru) Быстродействующая распадающаяся в ротовой полости пленка для проведения местного обезболивания
JP2019518569A (ja) 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス
AU2021325682A1 (en) Antimicrobial matrix formed from peptide hydrogels
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
JP5822724B2 (ja) 疼痛、炎症、ニューロンもしくは血管損傷に対する生物学的マーカーおよび治療への応答、ならびにその使用方法
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola